Anaemia and aluminium chelation therapy in dialysis patients. 1988

C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen

UI MeSH Term Description Entries
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000535 Aluminum A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. Aluminium,Aluminium-27,Aluminum-27,Aluminium 27,Aluminum 27
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias

Related Publications

C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
May 1988, Lancet (London, England),
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
July 1983, Lancet (London, England),
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
January 1980, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
August 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
November 2015, Journal of inorganic biochemistry,
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
January 1985, Nephron,
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
November 1999, Vaccine,
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
January 2006, Contributions to nephrology,
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
April 1990, Lancet (London, England),
C Tielemans, and F Collart, and R Wens, and J Smeyers-Verbeeke, and I Van Hooff, and M Dratwa, and D Verbeelen
February 1990, Lancet (London, England),
Copied contents to your clipboard!